Furthermore, in vivo studies indicated that TrkB inhibition sensitizes CRC cells to anoikis and protects against metastasis in xenograft mouse models by blocking TrkB with either Trk inhibitors or by downregulating with short hairpin (sh) RNA, leading to a reduction in both the size and number of tumors [15]. This evidence concerns the gene NTRK2 and colorectal carcinoma.